COMMUNIQUÉS West-GlobeNewswire

Chimerix Announces Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 13:00

- AdVance Data to be Presented at EBMT Annual Meeting - - Oral and IV BCV Programs Remain on Track - - Conference Call at 8:30 a.m. ET Today - DURHAM, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a [...]

G1 Therapeutics to Present at Investor Conferences in March 2018

01/03/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., March 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]

Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

01/03/2018 - 13:00

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]

MPX Reports Q3 Fiscal 2018 Results

01/03/2018 - 13:00

TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (the “ Corporation ” or “ MPX ”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its third quarter period ended December 31, 2017. (CDN$) 3 [...]

Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Remains on Track for Commercial Launch by First Quarter 2019

01/03/2018 - 13:00

Completed submission of NDAs for oral and intravenous omadacycline for the treatment of pneumonia and skin infections Expanded medical affairs and payer account management teams in readiness for discussions with [...]

Cannabis Wheaton Income Corp. and Sundial Sign Definitive Agreement for $7,000,000 in Debt Financing

01/03/2018 - 13:00

VANCOUVER, British Columbia, March 01, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX-V: CBW ) ( "Cannabis Wheaton" or the " Company ") is pleased to announce that it has entered into a definitive agreement [...]

News Release: Proposed combination between Essilor and Luxottica approved without conditions by the European Commission

01/03/2018 - 12:47

Proposed combination between Essilor and Luxottica approved without conditions by the European Commission PDF Version of the news release Charenton-le-Pont, France and Milan, Italy ( March 1, 2018 ) - Essilor (Euronext [...]

Communiqué : La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica

01/03/2018 - 12:47

La Commission Européenne autorise sans condition le projet de rapprochement entre Essilor et Luxottica Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 1 er mars 2018) - Essilor (Euronext Paris [...]

Loxo Oncology Reports Fourth Quarter and Year-End 2017 Financial Results

01/03/2018 - 12:45

– Larotrectinib Rolling NDA Submission on Track for Completion in March – – LOXO-292 Phase 1 Clinical Data Update Expected in First Half 2018 – STAMFORD, Conn., March 01, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. ( [...]

Edge Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 12:30

Interim Analysis from EG-1962 Phase 3 NEWTON 2 Study in Aneurysmal Subarachnoid Hemorrhage Expected by the End of April 2018 Full Top-Line Data from NEWTON 2 Study Expected in Late 2018 BERKELEY HEIGHTS, N.J., March 01 [...]

Wright Medical Group N.V. to Present at Barclays Global Healthcare Conference

01/03/2018 - 12:00

AMSTERDAM, The Netherlands, March 01, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI ) announced today that it will present at Barclays Global Healthcare Conference on Thursday, March 15, 2018, at the [...]

PotNetwork Holding Inc. Generates Over $3,000,000 in Sales Over First 45 days of 2018

01/03/2018 - 12:00

FT LAUDERDALE, Fla., March 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD, Inc., just one and a half [...]

Shire plc : Total voting rights

01/03/2018 - 11:16

Total Voting Rights March 1, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies the [...]

BIOPHYTIS updates on SARA clinical study of Sarconeos in sarcopenia and presents four posters at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Miami

01/03/2018 - 08:00

Additional data confirm the relevance of the protocol and the compound in the clinical study SARA-INT phase 2B PARIS, March 01, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS) , a biotechnology company [...]

iCAD Granted CE Mark Approval in Europe for PowerLook Tomo Detection 2.0 Artificial Intelligence Solution

01/03/2018 - 08:00

Company’s Innovative Breast Cancer Detection Product is Compatible with Hologic, GE and Siemens Digital Breast Tomosynthesis Systems Significantly Expanding iCAD’s Global Market Opportunity VIENNA, Austria, March 01, [...]

Basilea names Adesh Kaul as new member of its Management Committee

01/03/2018 - 07:16

Basel, Switzerland, March 01, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Adesh Kaul will join Basilea's Management Committee as Chief Corporate Development Officer effective March 01, 2018. He [...]

Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis

01/03/2018 - 07:16

Novartis and Pear Therapeutics to collaborate on prescription software applications aimed to treat patients with schizophrenia and multiple sclerosis Collaboration combines Novartis' leadership in biomedical research [...]

Biocartis Group NV: BIOCARTIS ANNOUNCES 2017 RESULTS AND 2018 OUTLOOK

01/03/2018 - 07:03

PRESS RELEASE: REGULATED INFORMATION Thursday, 1 March 2018, 07:02 CET BIOCARTIS ANNOUNCES 2017 RESULTS AND 2018 OUTLOOK Mechelen, Belgium , 1 March 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an [...]

Biocartis Group NV: Biocartis Establishes R&D Center in the US

01/03/2018 - 07:02

PRESS RELEASE : 1 March 2018, 07:01 CET Biocartis Establishes R&D Center in the US Biocartis team strengthened with joining of Janssen Diagnostic's Idylla(TM) assay development team Mechelen, Belgium, 1 March 2018 [...]